Income Statement TIS Inc.

Equities

3626

JP3104890003

IT Services & Consulting

Market Closed - Japan Exchange Other stock markets 05:30:00 11/03/26 pm AEDT			5-day change	1st Jan Change
3,354.00 ^JPY	-0.50%		+8.51%	-36.20%

10/03	TIS Inc. authorizes a Buyback Plan.	CI
03/03	Jefferies Adjusts TIS' Price Target to 3,500 Yen From 5,230 Yen, Keeps at Hold	MT

615544a495c318ea2396bd3.ljYZbQuSqaeBPPjktksA_-4pjos5_g5cYxvzyw5xxgk.2HVTOGLZ08vyapzR8Q94mKhq1-5qh00NCiihu1YF92_CZyocQdSR0Op6jw

Published financial data: TIS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	448B	483B	508B	549B	572B
Total Revenues	448B	483B	508B	549B	572B
Cost of Goods Sold, Total	335B	354B	367B	397B	411B
Gross Profit	114B	129B	142B	152B	160B
Selling General & Admin Expenses, Total	67.79B	74.11B	79.33B	87.1B	91.23B
Provision for Bad Debts	2.23B	60M	76M	-2.53B	-73M
Other Operating Expenses, Total	70.02B	74.17B	79.4B	84.57B	91.15B
Operating Income	43.7B	54.68B	62.33B	67.07B	69.05B
Interest Expense, Total	-227M	-322M	-235M	-380M	-495M
Interest And Investment Income	1.09B	1.26B	1.34B	1.09B	1.18B
Net Interest Expenses	866M	934M	1.11B	710M	685M
Income (Loss) On Equity Invest.	-6.03B	-1.01B	-1.09B	-20M	833M
Currency Exchange Gains (Loss)	-	480M	385M	497M	-
Other Non Operating Income (Expenses)	728M	627M	470M	295M	-70M
EBT, Excl. Unusual Items	39.26B	55.71B	63.2B	68.55B	70.5B
Gain (Loss) On Sale Of Investments	8.39B	7.77B	19.34B	872M	7.27B
Gain (Loss) On Sale Of Assets	3M	-	-	-	-
Asset Writedown	-2.47B	-1.47B	-969M	-1.09B	-4.24B
Other Unusual Items	-363M	-525M	-79M	861M	613M
EBT, Incl. Unusual Items	44.82B	61.48B	81.49B	69.19B	74.15B
Income Tax Expense	16.56B	20.29B	22.92B	18.94B	22.13B
Earnings From Continuing Operations	28.25B	41.19B	58.57B	50.25B	52.01B
Net Income to Company	28.25B	41.19B	58.57B	50.25B	52.01B
Minority Interest	-561M	-1.73B	-3.11B	-1.38B	-2B
Net Income - (IS)	27.69B	39.46B	55.46B	48.87B	50.01B
Net Income to Common Incl Extra Items	27.69B	39.46B	55.46B	48.87B	50.01B
Net Income to Common Excl. Extra Items	27.69B	39.46B	55.46B	48.87B	50.01B
Per Share Items
Net EPS - Basic	110.51	157.69	227.1	203.28	214.99
Basic EPS - Continuing Operations	110.51	157.69	227.1	203.28	214.99
Basic Weighted Average Shares Outstanding	251M	250M	244M	240M	233M
Net EPS - Diluted	110.51	157.69	227.1	203.28	214.99
Diluted EPS - Continuing Operations	110.51	157.69	227.1	203.28	214.99
Diluted Weighted Average Shares Outstanding	251M	250M	244M	240M	233M
Normalized Basic EPS	95.68	132.22	149.03	172.48	180.82
Normalized Diluted EPS	95.68	132.22	149.03	172.48	180.82
Dividend Per Share	35	44	50	56	70
Payout Ratio	28.2	23.64	20.65	25.79	34.33
Supplemental Items
EBITDA	57.24B	70.65B	78.19B	85.03B	88.62B
EBITA	43.92B	55.57B	62.49B	67.69B	69.87B
EBIT	43.7B	54.68B	62.33B	67.07B	69.05B
Effective Tax Rate - (Ratio)	36.96	33	28.13	27.38	29.85
Normalized Net Income	23.97B	33.09B	36.39B	41.47B	42.06B
Non-Cash Pension Expense	556M	4.42B	-436M	-218M	-495M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.79B	2.78B	3.1B	2.96B	3.08B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	83.32B	114B	94.68B	104B	84.01B
Short Term Investments	286M	298M	284M	281M	38.72B
Total Cash And Short Term Investments	83.6B	114B	94.96B	104B	123B
Accounts Receivable, Total	116B	115B	136B	148B	155B
Total Receivables	116B	115B	136B	148B	155B
Inventory	6.19B	3.03B	5.48B	5.57B	6.48B
Prepaid Expenses	-	-	27.81B	30.22B	30.94B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	24.47B	26.67B	4.86B	3.87B	3.71B
Total Current Assets	230B	259B	269B	292B	319B
Net Property Plant And Equipment	64.2B	65.39B	62.32B	69.72B	81B
Long-term Investments	117B	106B	82.49B	87.98B	92.53B
Goodwill	1.59B	770M	692M	9.66B	7.86B
Other Intangibles, Total	29.56B	27.98B	26.98B	46.14B	40.86B
Deferred Tax Assets Long-Term	8.44B	17.31B	21.16B	20.4B	16.72B
Other Long-Term Assets, Total	2M	1M	2M	2M	2M
Total Assets	451B	477B	462B	525B	558B
Liabilities
Accounts Payable, Total	26.47B	22.48B	26.98B	26.21B	28.95B
Accrued Expenses, Total	15.4B	15.84B	17.54B	16.95B	17.76B
Short-term Borrowings	5.79B	35.23B	11.99B	17.4B	22.21B
Current Income Taxes Payable	8.83B	21.86B	13.35B	9.02B	12.97B
Other Current Liabilities	44.42B	43.83B	47.32B	70.7B	71.32B
Total Current Liabilities	101B	139B	117B	140B	153B
Long-Term Debt	37.33B	2.21B	4.05B	20.51B	14.77B
Long-Term Leases	4.63B	3.55B	4.01B	4.76B	4.09B
Pension & Other Post Retirement Benefits	12.9B	12.53B	12.04B	12.81B	11.92B
Deferred Tax Liability Non Current	1.3B	667M	616M	8.78B	9.04B
Other Non Current Liabilities	14.58B	15.45B	15.2B	13.6B	8.96B
Total Liabilities	172B	174B	153B	201B	202B
Common Stock, Total	10B	10B	10B	10B	10B
Additional Paid In Capital	84.34B	64.96B	40.47B	12.31B	12.29B
Retained Earnings	173B	203B	247B	284B	316B
Treasury Stock	-18.81B	-3.12B	-7.61B	-6.4B	-11.96B
Comprehensive Income and Other	21.72B	18.02B	6.92B	12.96B	16.64B
Total Common Equity	270B	293B	297B	312B	343B
Minority Interest	8.95B	9.87B	12.19B	12.32B	12.72B
Total Equity	279B	303B	309B	325B	356B
Total Liabilities And Equity	451B	477B	462B	525B	558B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	251M	245M	242M	234M	232M
ECS Total Common Shares Outstanding	251M	250M	242M	234M	232M
Book Value / Share	1.08K	1.17K	1.23K	1.33K	1.48K
Tangible Book Value	239B	264B	269B	257B	295B
Tangible Book Value Per Share	954.38	1.06K	1.11K	1.1K	1.27K
Total Debt	47.75B	41B	20.05B	42.67B	41.07B
Net Debt	-35.86B	-73.5B	-74.91B	-61.16B	-81.66B
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.52B	5.88B	3.95B	2.05B	-998M
Minority Interest, Total (Incl. Fin. Div)	8.95B	9.87B	12.19B	12.32B	12.72B
Inventories - Raw Materials, Total	237M	217M	207M	193M	186M
Inventories - Work In Process, Total	2.98B	1.36B	1.76B	1.43B	966M
Inventories - Finished Goods, Total	2.97B	1.45B	3.52B	3.95B	5.33B
Full Time Employees	21.82K	21.71K	21.95K	21.97K	21.76K
Accumulated Allowance for Doubtful Accounts (Supple)	290M	308M	461M	392M	280M
Order Backlog	83.8B	94.02B	180B	188B	198B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	44.82B	61.48B	81.49B	69.19B	74.15B
Depreciation & Amortization - CF	13.32B	15.08B	15.7B	17.34B	18.75B
Amortization of Goodwill and Intangible Assets - (CF)	226M	889M	157M	619M	818M
Depreciation & Amortization, Total	13.54B	15.97B	15.86B	17.96B	19.57B
(Gain) Loss From Sale Of Asset	2.83B	1.29B	1.1B	1.2B	4.34B
(Gain) Loss on Sale of Investments - (CF)	-8.37B	-7.73B	-19.34B	-867M	-8.12B
(Income) Loss On Equity Investments - (CF)	6.03B	1.01B	1.09B	20M	-833M
Other Operating Activities, Total	-16.37B	-14.34B	-29.78B	-23.44B	-15.75B
Change In Accounts Receivable	-8.9B	1.72B	-18.79B	-10.57B	-5.6B
Change In Inventories	3.82B	1.74B	-2.32B	258M	-999M
Change In Accounts Payable	-2.92B	-668M	3.25B	736M	-1.02B
Change in Other Net Operating Assets	-1.14B	-4.35B	1.07B	8.09B	-1.97B
Cash from Operations	33.34B	56.13B	33.63B	62.58B	63.75B
Capital Expenditure	-10.06B	-9.05B	-4.34B	-13.08B	-18.82B
Sale of Property, Plant, and Equipment	898M	62M	50M	495M	154M
Cash Acquisitions	-1.66B	-	-	-20.72B	-
Divestitures	-	7.02B	2.44B	-	-
Sale (Purchase) of Intangible assets	-11.46B	-6.23B	-6.04B	-5.85B	-6.59B
Investment in Marketable and Equity Securities, Total	8.33B	4.38B	19.49B	4.21B	8.66B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-3.31B	-	-	2.96B	788M
Other Investing Activities, Total	-262M	394M	-297M	-826M	-1.93B
Cash from Investing	-17.52B	-3.42B	11.3B	-32.82B	-17.74B
Short Term Debt Issued, Total	-	1.32B	10.4B	-	-
Long-Term Debt Issued, Total	23.54B	-	3.5B	23.16B	7.2B
Total Debt Issued	23.54B	1.32B	13.9B	23.16B	7.2B
Short Term Debt Repaid, Total	-	-	-	-77M	-1.21B
Long-Term Debt Repaid, Total	-1.47B	-7.01B	-35.45B	-1.8B	-7.04B
Total Debt Repaid	-1.47B	-7.01B	-35.45B	-1.88B	-8.25B
Issuance of Common Stock	4.42B	1.15B	1.02B	7.65B	2.28B
Repurchase of Common Stock	-6.57B	-4.83B	-30B	-34.58B	-7.86B
Common Dividends Paid	-7.81B	-9.33B	-11.45B	-12.6B	-17.17B
Common & Preferred Stock Dividends Paid	-7.81B	-9.33B	-11.45B	-12.6B	-17.17B
Other Financing Activities, Total	369M	-3.25B	-2.58B	-3.63B	-3.98B
Cash from Financing	12.48B	-21.95B	-64.57B	-21.89B	-27.79B
Foreign Exchange Rate Adjustments	-50M	142M	271M	543M	351M
Miscellaneous Cash Flow Adjustments	-17M	-1M	-146M	-	-1M
Net Change in Cash	28.24B	30.9B	-19.51B	8.42B	18.57B
Supplemental Items
Cash Interest Paid	218M	303M	239M	374M	453M
Cash Income Tax Paid (Refund)	16.48B	14.36B	29.71B	23.64B	15.83B
Levered Free Cash Flow	6.93B	45.14B	16.51B	44.4B	36.49B
Unlevered Free Cash Flow	7.07B	45.34B	16.66B	44.64B	36.8B
Change In Net Working Capital	12.26B	-10.48B	27.77B	-3.69B	511M
Net Debt Issued / Repaid	22.07B	-5.69B	-21.55B	21.28B	-1.05B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.55	7.37	8.3	8.49	7.97
Return on Total Capital	9.12	10.18	11.57	12.03	11.29
Return On Equity %	10.71	14.15	19.13	15.85	15.28
Return on Common Equity	10.8	14	18.8	16.04	15.25
Margin Analysis
Gross Profit Margin %	25.36	26.7	27.88	27.62	28.02
SG&A Margin	15.12	15.36	15.6	15.86	15.96
EBITDA Margin %	12.77	14.64	15.38	15.49	15.5
EBITA Margin %	9.8	11.52	12.29	12.33	12.22
EBIT Margin %	9.75	11.33	12.26	12.22	12.08
Income From Continuing Operations Margin %	6.3	8.54	11.52	9.15	9.1
Net Income Margin %	6.18	8.18	10.91	8.9	8.75
Net Avail. For Common Margin %	6.18	8.18	10.91	8.9	8.75
Normalized Net Income Margin	5.35	6.86	7.16	7.55	7.36
Levered Free Cash Flow Margin	1.55	9.36	3.25	8.09	6.38
Unlevered Free Cash Flow Margin	1.58	9.4	3.28	8.13	6.44
Asset Turnover
Asset Turnover	1.08	1.04	1.08	1.11	1.06
Fixed Assets Turnover	7.58	7.45	7.96	8.32	7.59
Receivables Turnover (Average Receivables)	4.13	4.18	4.06	3.87	3.77
Inventory Turnover (Average Inventory)	49	76.75	86.13	71.9	68.28
Short Term Liquidity
Current Ratio	2.28	1.86	2.29	2.08	2.08
Quick Ratio	1.98	1.65	1.97	1.8	1.81
Operating Cash Flow to Current Liabilities	0.33	0.4	0.29	0.45	0.42
Days Sales Outstanding (Average Receivables)	88.45	87.28	89.97	94.54	96.82
Days Outstanding Inventory (Average Inventory)	7.45	4.76	4.24	5.09	5.35
Average Days Payable Outstanding	27.29	25.48	24.45	24.49	24.41
Cash Conversion Cycle (Average Days)	68.61	66.55	69.76	75.15	77.75
Long Term Solvency
Total Debt/Equity	17.09	13.53	6.48	13.14	11.54
Total Debt / Total Capital	14.59	11.92	6.09	11.61	10.34
LT Debt/Equity	15.01	1.9	2.61	7.78	5.3
Long-Term Debt / Total Capital	12.82	1.68	2.45	6.88	4.75
Total Liabilities / Total Assets	38.05	36.43	33.11	38.2	36.2
EBIT / Interest Expense	192.49	169.81	265.23	176.5	139.5
EBITDA / Interest Expense	252.16	219.42	332.71	223.76	179.03
(EBITDA - Capex) / Interest Expense	207.85	191.32	314.25	189.34	141.01
Total Debt / EBITDA	0.83	0.58	0.26	0.5	0.46
Net Debt / EBITDA	-0.63	-1.04	-0.96	-0.72	-0.92
Total Debt / (EBITDA - Capex)	1.01	0.67	0.27	0.59	0.59
Net Debt / (EBITDA - Capex)	-0.76	-1.19	-1.01	-0.85	-1.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.05	7.62	5.36	7.99	4.13
Gross Profit, 1 Yr. Growth %	7.38	13.31	10	6.99	5.65
EBITDA, 1 Yr. Growth %	0.42	23.43	10.66	8.75	4.22
EBITA, 1 Yr. Growth %	-2.35	26.52	12.45	8.33	3.22
EBIT, 1 Yr. Growth %	-2.55	25.14	13.99	7.61	2.96
Earnings From Cont. Operations, 1 Yr. Growth %	-6.96	45.8	42.18	-14.21	3.51
Net Income, 1 Yr. Growth %	-5.84	42.5	40.54	-11.88	2.33
Normalized Net Income, 1 Yr. Growth %	-13.88	38.01	9.99	13.94	1.43
Diluted EPS Before Extra, 1 Yr. Growth %	-5.37	42.69	44.02	-10.49	5.76
Accounts Receivable, 1 Yr. Growth %	13.88	-0.55	17.82	9.21	4.83
Inventory, 1 Yr. Growth %	-17.24	-51	80.9	1.6	16.35
Net Property, Plant and Equip., 1 Yr. Growth %	18.79	1.86	-4.7	11.87	16.19
Total Assets, 1 Yr. Growth %	17.8	5.67	-3	13.66	6.2
Tangible Book Value, 1 Yr. Growth %	9.7	10.46	1.89	-4.74	14.82
Common Equity, 1 Yr. Growth %	11.63	8.37	1.34	5.17	9.9
Cash From Operations, 1 Yr. Growth %	-13.54	68.32	-40.07	86.06	1.87
Capital Expenditures, 1 Yr. Growth %	65.09	-10.05	-52.07	201.61	43.87
Levered Free Cash Flow, 1 Yr. Growth %	-62.89	551.51	-63.42	168.91	-17.81
Unlevered Free Cash Flow, 1 Yr. Growth %	-62.42	541.28	-63.26	167.96	-17.56
Dividend Per Share, 1 Yr. Growth %	16.67	25.71	13.64	12	25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.23	4.28	6.48	6.66	6.04
Gross Profit, 2 Yr. CAGR %	9.53	10.31	11.64	8.48	6.32
EBITDA, 2 Yr. CAGR %	5.94	11.33	16.87	9.7	6.46
EBITA, 2 Yr. CAGR %	7.21	11.15	19.28	10.37	5.75
EBIT, 2 Yr. CAGR %	7.17	10.43	19.43	10.75	5.26
Earnings From Cont. Operations, 2 Yr. CAGR %	2.77	16.47	43.98	10.45	-5.76
Net Income, 2 Yr. CAGR %	3.14	15.83	41.52	11.29	-5.04
Normalized Net Income, 2 Yr. CAGR %	1.19	9.02	23.21	11.95	7.51
Diluted EPS Before Extra, 2 Yr. CAGR %	3.78	16.2	43.35	13.54	-2.7
Accounts Receivable, 2 Yr. CAGR %	12.23	6.42	8.24	13.43	7
Inventory, 2 Yr. CAGR %	-18.62	-36.32	-5.85	35.57	8.73
Net Property, Plant and Equip., 2 Yr. CAGR %	-6.3	10	-1.47	3.25	14.01
Total Assets, 2 Yr. CAGR %	10.32	11.57	1.24	5	9.87
Tangible Book Value, 2 Yr. CAGR %	6.98	10.08	6.09	-1.48	4.58
Common Equity, 2 Yr. CAGR %	8.53	9.99	4.79	3.24	7.51
Cash From Operations, 2 Yr. CAGR %	-5.78	20.63	0.43	5.59	37.67
Capital Expenditures, 2 Yr. CAGR %	22.92	21.86	-34.34	20.24	108.31
Levered Free Cash Flow, 2 Yr. CAGR %	-59.24	55.5	54.37	-0.83	48.66
Unlevered Free Cash Flow, 2 Yr. CAGR %	-58.92	55.24	53.49	-0.78	48.63
Dividend Per Share, 2 Yr. CAGR %	22.47	21.11	19.52	12.82	18.32
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.4	4.67	4.64	6.98	5.81
Gross Profit, 3 Yr. CAGR %	10.46	10.78	10.2	10.07	7.53
EBITDA, 3 Yr. CAGR %	7.96	11.48	11.11	14.1	7.85
EBITA, 3 Yr. CAGR %	10.09	13.29	11.58	15.51	7.93
EBIT, 3 Yr. CAGR %	10.1	12.85	11.6	15.35	8.09
Earnings From Cont. Operations, 3 Yr. CAGR %	9.8	15.48	24.48	21.16	8.08
Net Income, 3 Yr. CAGR %	10.33	14.87	23.55	20.85	8.22
Normalized Net Income, 3 Yr. CAGR %	6.63	12.22	9.35	20.04	8.33
Diluted EPS Before Extra, 3 Yr. CAGR %	11.15	15.4	24.82	22.52	10.88
Accounts Receivable, 3 Yr. CAGR %	5.4	7.8	10.09	8.57	10.49
Inventory, 3 Yr. CAGR %	-12.46	-31.28	-9.81	-3.43	28.84
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.34	-3.66	4.86	2.79	7.4
Total Assets, 3 Yr. CAGR %	6.87	8.74	6.48	5.22	5.4
Tangible Book Value, 3 Yr. CAGR %	5.69	8.13	7.28	2.35	3.68
Common Equity, 3 Yr. CAGR %	6.86	8.48	7.02	4.92	5.41
Cash From Operations, 3 Yr. CAGR %	-2.87	14.33	-4.46	23.35	4.34
Capital Expenditures, 3 Yr. CAGR %	0.14	10.77	-10.71	9.15	27.65
Levered Free Cash Flow, 3 Yr. CAGR %	-24.63	2.68	-4.01	85.74	-6.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	-24.44	2.67	-3.98	84.82	-6.72
Dividend Per Share, 3 Yr. CAGR %	37.95	23.55	18.56	16.96	16.74
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.22	4.17	4.62	5.46	5.2
Gross Profit, 5 Yr. CAGR %	10.02	11.15	10.93	9.85	8.63
EBITDA, 5 Yr. CAGR %	9.36	12.6	11.44	10.77	9.23
EBITA, 5 Yr. CAGR %	12.25	15.34	13.68	12.11	9.21
EBIT, 5 Yr. CAGR %	12.33	15.14	13.74	12.01	9.02
Earnings From Cont. Operations, 5 Yr. CAGR %	16.6	19.73	22.37	13.44	11.36
Net Income, 5 Yr. CAGR %	16.91	19.33	21.88	13.42	11.2
Normalized Net Income, 5 Yr. CAGR %	9.99	14.94	12.98	12.11	8.61
Diluted EPS Before Extra, 5 Yr. CAGR %	17.95	20.14	23.06	14.65	12.98
Accounts Receivable, 5 Yr. CAGR %	4.94	3.28	6.53	10.02	8.84
Inventory, 5 Yr. CAGR %	-8.58	-19.75	-9.87	-9.82	-2.81
Net Property, Plant and Equip., 5 Yr. CAGR %	-3.12	-2.93	-3.81	-0.95	8.43
Total Assets, 5 Yr. CAGR %	6.04	7.14	4.58	7.23	7.82
Tangible Book Value, 5 Yr. CAGR %	8.62	8.43	5.85	4.18	6.19
Common Equity, 5 Yr. CAGR %	8.91	8.49	6.03	6.35	7.22
Cash From Operations, 5 Yr. CAGR %	5.51	24.25	-1.56	10.75	10.57
Capital Expenditures, 5 Yr. CAGR %	16.45	-1.04	-15.42	14.46	25.3
Levered Free Cash Flow, 5 Yr. CAGR %	-20.6	86.12	0.4	1.26	14.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	-20.49	90.62	0.32	1.27	14.36
Dividend Per Share, 5 Yr. CAGR %	26.05	29.67	30.26	19.14	18.47